A treatment regimen for SARS in Guangzhou, China
Extracted & modified from Zhao Z, et al. J Med Microbiol 2003; 52: 715-20
Levofloxacin 200 mg twice daily plus azithromycin 600 mg daily intravenously.
Recombinant interferon α 3.000.000 U daily intramuscularly (for 75% of their cases).
If patients failed to respond (continuing high fever), with pulmonary infiltrates involving more than one pulmonary segment, or an expanding area of consolidation was observed, they were treated with high-dose methylprednisolone for 5-14 days (1601000 mg daily depending on symptoms and X-ray results: 160 mg daily if one lobe was involved; 320 mg daily if >1 lobe; 25% needed an increase in dosage from 160 to 320-720 mg daily to maintain respiratory physiological parameters and to control temperature).
Oxygen 3-5 L per min was given by mask if SaO2 <95% or, if patients felt short of breath, non-invasive continuous positive airway pressure (CPAP) ventilation was used.
If CPAP failed (SaO2 <90%), mechanical ventilation was used.
Immunoglobulins, thymic peptides or recombinant human thymus proteins were given to some critically ill patients.
- April 8-10
- April 12
- June 6
- August 14
- September 8
- September 24
- References
- 30 Virology
- Discovery of the SARS Virus
- Initial Research
- Coronaviridae
- SARS Co-V
- Genome Sequence
- Antiviral Agents and Vaccines
- Antiviral Drugs
- Vaccines
- Outlook
- References
- Routes of Transmission
- Patient Factors in Transmission
- Asymptomatic Patients
- Symptomatic Patients
- The Unsuspected Patients
- High-Risk Activities
- Transmission during Quarantine
- Introduction
- Global Spread
- Hong Kong
- Other Countries
- Eradication
- Outlook
- Introduction
- International Coordination
- Management of SARS in the post-outbreak period
- National Measures
- Legislation
- Quarantine after Discharge
- Infection Control in Healthcare Settings
- General Measures
- Protective Measures
- Special Settings
- Intensive Care Units
- Intubating a SARS Patient
- Anesthesia
- Triage
- Internet Sources
- After the Outbreak
- Conclusion
- 108 Case Definition
- WHO Case Definition
- Suspect case
- Reclassification of cases
- CDC Case Definition
- 112 Diagnostic Tests
- Introduction
- Laboratory tests
- Virus isolation
- Antibody detection
- Interpretation
- Limitations
- Biosafety considerations
- Clinical Presentation and Diagnosis
- Clinical Presentation
- Diagnosis
- Clinical Course
- Histopathology
- Lung Biopsy
- Postmortem Findings
- Discharge and Follow-up
- Psychosocial Issues
- References
- 144 SARS Treatment
- Antibiotic therapy
- Antiviral therapy
- Ribavirin
- Alternative medicine
- Immunomodulatory therapy
- Other immunomodulators
- Assisted ventilation
- Invasive mechanical ventilation
- Clinical outcomes
- Appendix 1
- A standardized treatment protocol for adult SARS in Hong Kong
- Appendix 2
- A treatment regimen for SARS in Guangzhou, China
- References
- 168 Pediatric SARS
- Clinical Manifestation